(1->4)-beta-D-glucan multiple interactions ISO RGD:731885 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ALPL mRNA CTD PMID:36331819 (E)-thiamethoxam increases activity EXP 6480464 Thiamethoxam results in increased activity of ALPL protein CTD PMID:30621503 (E)-thiamethoxam multiple interactions EXP 6480464 [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of ALPL protein] CTD PMID:30621503 (R,R)-tramadol multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Tramadol results in increased expression of ALPL protein] CTD PMID:31618080 (R,R)-tramadol increases expression EXP 6480464 Tramadol results in increased expression of ALPL protein CTD PMID:31618080 (S)-mandelic acid multiple interactions ISO RGD:1346147 6480464 [[Volatile Organic Compounds results in increased abundance of Styrene] which results in increased abundance of mandelic acid] which results in increased expression of ALPL protein CTD PMID:34668566 (S)-naringenin multiple interactions ISO RGD:1346147 6480464 [naringenin binds to ESR1 protein] which results in increased activity of ALPL protein, fulvestrant inhibits the reaction [[naringenin binds to ESR1 protein] which results in increased activity of ALPL protein] CTD PMID:12650720 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions ISO RGD:1346147 6480464 o, p'-DDT inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 1,3-dinitrobenzene affects expression EXP 6480464 3-dinitrobenzene affects the expression of ALPL mRNA CTD PMID:24140754 1-(5-isoquinolinesulfonyl)-2-methylpiperazine decreases activity EXP 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine results in decreased activity of ALPL protein CTD PMID:11171635 1-naphthyl isothiocyanate multiple interactions ISO RGD:731885 6480464 RAG1 gene mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ALPL protein] CTD PMID:28049044 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ALPL mRNA CTD PMID:30723492 1-naphthyl isothiocyanate increases secretion EXP 6480464 1-Naphthylisothiocyanate results in increased secretion of ALPL protein CTD PMID:27702592 1-naphthyl isothiocyanate increases expression ISO RGD:731885 6480464 1-Naphthylisothiocyanate results in increased expression of ALPL protein CTD PMID:28049044 1-naphthyl isothiocyanate multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in increased secretion of ALPL protein] CTD PMID:27702592 1-octadec-9-enoylglycero-3-phosphate multiple interactions ISO RGD:1346147 6480464 [Lithocholic Acid co-treated with lysophosphatidic acid] results in increased activity of ALPL protein CTD PMID:19646460 17alpha-ethynylestradiol multiple interactions ISO RGD:1346147 6480464 VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein] CTD PMID:12521655 17alpha-ethynylestradiol increases secretion ISO RGD:731885 6480464 Ethinyl Estradiol results in increased secretion of ALPL protein CTD PMID:36329302 17alpha-ethynylestradiol multiple interactions ISO RGD:731885 6480464 [Ethinyl Estradiol co-treated with IL17A protein] results in increased secretion of ALPL protein more ... CTD PMID:36329302 17beta-estradiol multiple interactions ISO RGD:1346147 6480464 [Estradiol binds to ESR1 protein] which results in increased activity of ALPL protein more ... CTD PMID:12650720 more ... 17beta-estradiol increases expression ISO RGD:731885 6480464 Estradiol results in increased expression of ALPL mRNA CTD PMID:15289156 , PMID:19484750 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:731885 6480464 Dihydrotestosterone results in increased expression of ALPL mRNA CTD PMID:17898587 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1346147 6480464 2 more ... CTD PMID:23146750 2,2',5,5'-tetrachlorobiphenyl increases expression ISO RGD:731885 6480464 2 more ... CTD PMID:25795401 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RGD:1346147 6480464 2 more ... CTD PMID:36804509 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731885 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ALPL mRNA] more ... CTD PMID:22749964 more ... 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO RGD:1346147 6480464 Tetrachlorodibenzodioxin results in increased activity of ALPL protein CTD PMID:30203000 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731885 6480464 Tetrachlorodibenzodioxin results in decreased expression of ALPL mRNA, Tetrachlorodibenzodioxin results in decreased expression of ALPL protein CTD PMID:22749964 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731885 6480464 Tetrachlorodibenzodioxin affects the expression of ALPL mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1346147 6480464 Tetrachlorodibenzodioxin results in increased expression of ALPL mRNA, Tetrachlorodibenzodioxin results in increased expression of ALPL protein CTD PMID:18724896 , PMID:30203000 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of ALPL protein], resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ALPL mRNA] CTD PMID:11018766 2,3,7,8-tetrachlorodibenzodioxine decreases activity EXP 6480464 Tetrachlorodibenzodioxin results in decreased activity of ALPL protein CTD PMID:11018766 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1346147 6480464 Tetrachlorodibenzodioxin affects the expression of ALPL mRNA CTD PMID:20106945 , PMID:36370075 2-acetamidofluorene multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein more ... CTD PMID:15548946 , PMID:15554553 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:1346147 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucosamine analog results in increased activity of ALPL protein] CTD PMID:20458730 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:1346147 6480464 Glucosamine analog results in increased expression of ALPL mRNA CTD PMID:20458730 2-amino-2-deoxy-D-glucopyranose increases activity ISO RGD:1346147 6480464 Glucosamine analog results in increased activity of ALPL protein CTD PMID:20458730 2-butoxyethanol decreases expression ISO RGD:731885 6480464 n-butoxyethanol results in decreased expression of ALPL mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:731885 6480464 tetrabromobisphenol A results in decreased expression of ALPL protein CTD PMID:25777084 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione decreases activity EXP 6480464 bisindolylmaleimide I results in decreased activity of ALPL protein CTD PMID:11171635 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1346147 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ALPL mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of ALPL protein CTD PMID:11289319 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1346147 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ALPL mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol affects methylation ISO RGD:731885 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of ALPL gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases expression ISO RGD:731885 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of ALPL mRNA CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:731885 6480464 Fenretinide results in increased expression of ALPL mRNA CTD PMID:28973697 5-(2-methylpiperazine-1-sulfonyl)isoquinoline decreases activity EXP 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine results in decreased activity of ALPL protein CTD PMID:11171635 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 Raloxifene Hydrochloride inhibits the reaction [Decitabine results in increased expression of ALPL mRNA] CTD PMID:23385821 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of ALPL mRNA CTD PMID:23385821 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ALPL mRNA CTD PMID:22504374 , PMID:30047161 6alpha-methylprednisolone increases secretion EXP 6480464 Methylprednisolone results in increased secretion of ALPL protein CTD PMID:30291735 6alpha-methylprednisolone multiple interactions EXP 6480464 Alendronate inhibits the reaction [Methylprednisolone results in increased secretion of ALPL protein], Nebivolol promotes the reaction [Alendronate inhibits the reaction [Methylprednisolone results in increased secretion of ALPL protein]] CTD PMID:30291735 acephate multiple interactions ISO RGD:1346147 6480464 acephate inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 acetamide increases expression EXP 6480464 acetamide results in increased expression of ALPL mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1346147 6480464 [[Volatile Organic Compounds results in increased abundance of Acrolein] which results in increased abundance of S-(2-carboxyethyl)-N-acetylcysteine] which results in increased expression of ALPL protein, [[Volatile Organic Compounds results in increased abundance of Acrolein] which results in increased abundance of S-(3-hydroxypropyl)cysteine N-acetate] which results in increased expression of ALPL protein CTD PMID:34668566 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of ALPL mRNA CTD PMID:28959563 acrylamide multiple interactions ISO RGD:1346147 6480464 [[Volatile Organic Compounds results in increased abundance of Acrylamide] which results in increased abundance of N-acetyl-S-(2-carbamoylethyl)cysteine] which results in increased expression of ALPL protein CTD PMID:34668566 acrylonitrile multiple interactions ISO RGD:1346147 6480464 [[Volatile Organic Compounds results in increased abundance of Acrylonitrile] which results in increased abundance of N-acetyl-S-(2-cyanoethyl)cysteine] which results in increased expression of ALPL protein CTD PMID:34668566 Actein multiple interactions ISO RGD:731885 6480464 actein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ALPL mRNA], actein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ALPL protein] CTD PMID:28836330 aflatoxin B1 affects expression ISO RGD:1346147 6480464 Aflatoxin B1 affects the expression of ALPL protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1346147 6480464 Aflatoxin B1 results in decreased methylation of ALPL intron CTD PMID:30157460 aflatoxin B1 increases secretion ISO RGD:731885 6480464 Aflatoxin B1 results in increased secretion of ALPL protein CTD PMID:37030333 aflatoxin B1 multiple interactions ISO RGD:731885 6480464 fexaramine inhibits the reaction [Aflatoxin B1 results in increased secretion of ALPL protein] CTD PMID:37030333 alachlor multiple interactions ISO RGD:1346147 6480464 alachlor inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 aldehydo-D-glucosamine multiple interactions ISO RGD:1346147 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucosamine analog results in increased activity of ALPL protein] CTD PMID:20458730 aldehydo-D-glucosamine increases expression ISO RGD:1346147 6480464 Glucosamine analog results in increased expression of ALPL mRNA CTD PMID:20458730 aldehydo-D-glucosamine increases activity ISO RGD:1346147 6480464 Glucosamine analog results in increased activity of ALPL protein CTD PMID:20458730 aldehydo-D-glucose multiple interactions ISO RGD:731885 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL protein]] more ... CTD PMID:33450223 aldehydo-D-glucose multiple interactions EXP 6480464 morroniside inhibits the reaction [Glucose results in decreased expression of ALPL mRNA] CTD PMID:32643284 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of ALPL mRNA CTD PMID:32643284 aldehydo-D-glucose decreases expression ISO RGD:731885 6480464 Glucose results in decreased expression of ALPL mRNA CTD PMID:33450223 aldosterone increases expression ISO RGD:1346147 6480464 Aldosterone results in increased expression of ALPL mRNA CTD PMID:29149346 aldosterone multiple interactions ISO RGD:1346147 6480464 acephate inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] more ... CTD PMID:29149346 alendronic acid multiple interactions EXP 6480464 Alendronate inhibits the reaction [Methylprednisolone results in increased secretion of ALPL protein], Nebivolol promotes the reaction [Alendronate inhibits the reaction [Methylprednisolone results in increased secretion of ALPL protein]] CTD PMID:30291735 all-trans-retinoic acid multiple interactions ISO RGD:1346147 6480464 Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] more ... CTD PMID:10567916 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of ALPL mRNA CTD PMID:10022522 , PMID:10567916 all-trans-retinoic acid increases activity EXP 6480464 Tretinoin results in increased activity of ALPL protein CTD PMID:10567916 , PMID:11171635 all-trans-retinoic acid decreases expression ISO RGD:1346147 6480464 Tretinoin results in decreased expression of ALPL mRNA CTD PMID:21934132 all-trans-retinoic acid multiple interactions EXP 6480464 EGF protein inhibits the reaction [Tretinoin results in increased activity of ALPL protein] more ... CTD PMID:10567916 , PMID:11171635 all-trans-retinoic acid increases expression ISO RGD:731885 6480464 Tretinoin results in increased expression of ALPL mRNA, Tretinoin results in increased expression of ALPL protein CTD PMID:10704935 , PMID:16604517 all-trans-retinoic acid increases activity ISO RGD:731885 6480464 Tretinoin results in increased activity of ALPL protein CTD PMID:10567916 all-trans-retinoic acid multiple interactions ISO RGD:731885 6480464 AGN 193109 inhibits the reaction [Indinavir promotes the reaction [Tretinoin results in increased expression of ALPL protein]] more ... CTD PMID:10567916 , PMID:10704935 all-trans-retinoic acid increases activity ISO RGD:1346147 6480464 Tretinoin results in increased activity of ALPL protein CTD PMID:10567916 allopurinol increases expression EXP 6480464 Allopurinol results in increased expression of ALPL mRNA CTD PMID:26968635 alloxanthine increases expression EXP 6480464 Oxypurinol results in increased expression of ALPL mRNA CTD PMID:26968635 aluminium atom multiple interactions ISO RGD:731885 6480464 [Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of ALPL mRNA, Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of ALPL mRNA] CTD PMID:34547296 aluminium oxide increases expression ISO RGD:1346147 6480464 Aluminum Oxide results in increased expression of ALPL mRNA CTD PMID:19464052 aluminium(0) multiple interactions ISO RGD:731885 6480464 [Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of ALPL mRNA, Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of ALPL mRNA] CTD PMID:34547296 amitrole increases expression EXP 6480464 Amitrole results in increased expression of ALPL mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ALPL mRNA CTD PMID:16483693 apocynin multiple interactions EXP 6480464 acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of ALPL mRNA] CTD PMID:24080574 Aroclor 1254 decreases expression ISO RGD:731885 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ALPL mRNA CTD PMID:25795401 arsane increases expression ISO RGD:1346147 6480464 Arsenic results in increased expression of ALPL protein CTD PMID:30890376 arsenic atom increases expression ISO RGD:1346147 6480464 Arsenic results in increased expression of ALPL protein CTD PMID:30890376 arsenite(3-) decreases expression ISO RGD:731885 6480464 arsenite results in decreased expression of ALPL mRNA CTD PMID:33053406 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of ALPL mRNA CTD PMID:22465848 ATP increases response to substance ISO RGD:731885 6480464 ALPL gene mutant form results in increased susceptibility to Adenosine Triphosphate CTD PMID:27466191 ATP multiple interactions ISO RGD:731885 6480464 ALPL gene mutant form promotes the reaction [Adenosine Triphosphate results in increased expression of FOS mRNA] CTD PMID:27466191 atrazine multiple interactions ISO RGD:1346147 6480464 Atrazine metabolite inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 benzo[a]pyrene increases expression ISO RGD:731885 6480464 Benzo(a)pyrene results in increased expression of ALPL mRNA CTD PMID:21567390 , PMID:21569818 benzo[a]pyrene decreases expression ISO RGD:1346147 6480464 Benzo(a)pyrene results in decreased expression of ALPL mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1346147 6480464 Benzo(a)pyrene affects the methylation of ALPL 5' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1346147 6480464 Benzo(a)pyrene results in increased methylation of ALPL promoter CTD PMID:27901495 benzo[e]pyrene decreases methylation ISO RGD:1346147 6480464 benzo(e)pyrene results in decreased methylation of ALPL intron CTD PMID:30157460 beta-D-glucosamine multiple interactions ISO RGD:1346147 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucosamine analog results in increased activity of ALPL protein] CTD PMID:20458730 beta-D-glucosamine increases expression ISO RGD:1346147 6480464 Glucosamine analog results in increased expression of ALPL mRNA CTD PMID:20458730 beta-D-glucosamine increases activity ISO RGD:1346147 6480464 Glucosamine analog results in increased activity of ALPL protein CTD PMID:20458730 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALPL mRNA CTD PMID:18164116 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of ALPL mRNA CTD PMID:16648578 bezafibrate decreases activity ISO RGD:1346147 6480464 Bezafibrate results in decreased activity of ALPL protein CTD PMID:8102192 bezafibrate increases expression ISO RGD:731885 6480464 Bezafibrate results in increased expression of ALPL mRNA CTD PMID:21499286 bezafibrate multiple interactions ISO RGD:731885 6480464 dorsomorphin inhibits the reaction [Bezafibrate results in increased expression of ALPL mRNA], GSK0660 inhibits the reaction [Bezafibrate results in increased expression of ALPL mRNA] CTD PMID:21499286 bifenthrin multiple interactions ISO RGD:1346147 6480464 bifenthrin inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of ALPL mRNA CTD PMID:22985736 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1346147 6480464 Diethylhexyl Phthalate results in increased expression of ALPL protein CTD PMID:31163220 bisphenol A multiple interactions ISO RGD:1346147 6480464 [bisphenol A binds to ESR1 protein] which results in increased activity of ALPL protein, [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ALPL gene CTD PMID:12650720 , PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ALPL mRNA CTD PMID:35192832 bisphenol A decreases expression ISO RGD:731885 6480464 bisphenol A results in decreased expression of ALPL mRNA CTD PMID:33221593 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ALPL mRNA CTD PMID:25181051 , PMID:32145629 bisphenol A decreases activity ISO RGD:731885 6480464 bisphenol A results in decreased activity of ALPL protein CTD PMID:23900028 bisphenol A decreases expression ISO RGD:1346147 6480464 bisphenol A results in decreased expression of ALPL mRNA CTD PMID:23146750 Butylparaben multiple interactions ISO RGD:731885 6480464 NR3C1 protein promotes the reaction [butylparaben results in decreased expression of ALPL mRNA], PPARG protein promotes the reaction [butylparaben results in decreased expression of ALPL mRNA] CTD PMID:28527915 Butylparaben decreases expression ISO RGD:731885 6480464 butylparaben results in decreased expression of ALPL mRNA CTD PMID:28527915 cadmium atom decreases expression ISO RGD:1346147 6480464 Cadmium results in decreased expression of ALPL mRNA CTD PMID:20570719 cadmium atom multiple interactions ISO RGD:1346147 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ALPL mRNA CTD PMID:32522577 cadmium atom decreases activity EXP 6480464 Cadmium results in decreased activity of ALPL protein CTD PMID:26214600 cadmium atom multiple interactions EXP 6480464 Cadmium inhibits the reaction [zinc chloride results in increased activity of ALPL protein], zinc chloride inhibits the reaction [Cadmium results in decreased activity of ALPL protein] CTD PMID:26214600 cadmium dichloride decreases expression ISO RGD:1346147 6480464 Cadmium Chloride results in decreased expression of ALPL mRNA CTD PMID:22019892 cadmium dichloride multiple interactions EXP 6480464 Melatonin inhibits the reaction [Cadmium Chloride results in decreased activity of ALPL protein], Melatonin inhibits the reaction [Cadmium Chloride results in decreased expression of ALPL mRNA] CTD PMID:31809235 cadmium dichloride decreases activity EXP 6480464 Cadmium Chloride results in decreased activity of ALPL protein CTD PMID:31809235 cadmium dichloride decreases activity ISO RGD:1346147 6480464 Cadmium Chloride results in decreased activity of ALPL protein CTD PMID:27558804 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of ALPL mRNA CTD PMID:22209727 , PMID:31809235 cadmium dichloride multiple interactions ISO RGD:1346147 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cadmium Chloride results in decreased expression of ALPL mRNA], [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ALPL mRNA CTD PMID:22019892 , PMID:32522577 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of ALPL mRNA CTD PMID:30423288 , PMID:31874197 calcidiol increases expression ISO RGD:1346147 6480464 Calcifediol results in increased expression of ALPL mRNA, Calcifediol results in increased expression of ALPL protein CTD PMID:21542014 calcidiol multiple interactions ISO RGD:1346147 6480464 CYP27B1 protein promotes the reaction [Calcifediol results in increased expression of ALPL mRNA] more ... CTD PMID:21542014 calcitriol increases expression ISO RGD:1346147 6480464 Calcitriol results in increased expression of ALPL mRNA, Calcitriol results in increased expression of ALPL protein CTD PMID:12016462 more ... calcitriol multiple interactions ISO RGD:731885 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL protein]] more ... CTD PMID:33450223 calcium dichloride increases expression ISO RGD:1346147 6480464 Calcium Chloride results in increased expression of ALPL mRNA CTD PMID:25824407 calcium dihydroxide increases expression ISO RGD:1346147 6480464 Calcium Hydroxide results in increased expression of ALPL mRNA CTD PMID:22083529 calcium silicate multiple interactions ISO RGD:731885 6480464 [Zinc binds to calcium silicate] which results in increased expression of ALPL mRNA CTD PMID:23483914 cannabidiol increases expression ISO RGD:1346147 6480464 Cannabidiol results in increased expression of ALPL mRNA CTD PMID:33872753 carbon nanotube increases expression ISO RGD:731885 6480464 Nanotubes more ... CTD PMID:25554681 carbonyl sulfide decreases expression EXP 6480464 carbonyl sulfide results in decreased expression of ALPL mRNA CTD PMID:19395590 CGP 52608 multiple interactions ISO RGD:1346147 6480464 CGP 52608 promotes the reaction [RORA protein binds to ALPL gene] CTD PMID:28238834 chitosan increases expression ISO RGD:1346147 6480464 Chitosan results in increased expression of ALPL mRNA, Chitosan results in increased expression of ALPL protein CTD PMID:25246786 chloramphenicol increases expression ISO RGD:1346147 6480464 Chloramphenicol results in increased expression of ALPL mRNA CTD PMID:22083529 chlorpyrifos multiple interactions ISO RGD:731885 6480464 [cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein, Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein] CTD PMID:15991261 chlorpyrifos increases expression ISO RGD:731885 6480464 Chlorpyrifos results in increased expression of ALPL mRNA CTD PMID:37019170 chromium atom decreases activity EXP 6480464 Chromium results in decreased activity of ALPL protein CTD PMID:16866188 chromium(3+) trichloride multiple interactions ISO RGD:731885 6480464 [cobaltous chloride co-treated with chromic chloride] results in decreased expression of ALPL protein CTD PMID:25966675 chromium(3+) trichloride decreases expression ISO RGD:731885 6480464 chromic chloride results in decreased expression of ALPL protein CTD PMID:25966675 clofibrate increases expression ISO RGD:731885 6480464 Clofibrate results in increased expression of ALPL mRNA CTD PMID:23811191 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ALPL mRNA CTD PMID:17602206 cobalt dichloride multiple interactions ISO RGD:1346147 6480464 cobaltous chloride affects the reaction [BMP2 protein results in increased expression of ALPL mRNA] more ... CTD PMID:21882223 , PMID:26054564 cobalt dichloride decreases expression ISO RGD:731885 6480464 cobaltous chloride results in decreased expression of ALPL mRNA, cobaltous chloride results in decreased expression of ALPL protein CTD PMID:16772336 , PMID:25966675 cobalt dichloride multiple interactions ISO RGD:731885 6480464 [cobaltous chloride co-treated with chromic chloride] results in decreased expression of ALPL protein more ... CTD PMID:23203800 , PMID:25966675 cobalt dichloride decreases expression ISO RGD:1346147 6480464 cobaltous chloride results in decreased expression of ALPL protein CTD PMID:21882223 copper atom increases expression EXP 6480464 Copper results in increased expression of ALPL mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of ALPL mRNA CTD PMID:30556269 corticosterone multiple interactions EXP 6480464 Enalapril inhibits the reaction [Corticosterone results in decreased expression of ALPL mRNA] CTD PMID:30423288 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of ALPL mRNA CTD PMID:30423288 coumestrol multiple interactions ISO RGD:1346147 6480464 [Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein, fulvestrant inhibits the reaction [[Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein] CTD PMID:12650720 cyanuric acid increases expression EXP 6480464 cyanuric acid results in increased expression of ALPL protein CTD PMID:36152796 cyclosporin A decreases expression ISO RGD:1346147 6480464 Cyclosporine results in decreased expression of ALPL mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1346147 6480464 Cyclosporine results in increased expression of ALPL protein CTD PMID:1790624 cypermethrin multiple interactions ISO RGD:731885 6480464 [cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein, Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein] CTD PMID:15991261 cypermethrin multiple interactions ISO RGD:1346147 6480464 cypermethrin inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 cypermethrin increases activity EXP 6480464 cypermethrin results in increased activity of ALPL protein CTD PMID:15365239 D-glucose multiple interactions ISO RGD:731885 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL protein]] more ... CTD PMID:33450223 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of ALPL mRNA CTD PMID:32643284 D-glucose multiple interactions EXP 6480464 morroniside inhibits the reaction [Glucose results in decreased expression of ALPL mRNA] CTD PMID:32643284 D-glucose decreases expression ISO RGD:731885 6480464 Glucose results in decreased expression of ALPL mRNA CTD PMID:33450223 daidzein multiple interactions ISO RGD:1346147 6480464 [daidzein binds to ESR1 protein] which results in increased activity of ALPL protein, fulvestrant inhibits the reaction [[daidzein binds to ESR1 protein] which results in increased activity of ALPL protein] CTD PMID:12650720 DDE multiple interactions ISO RGD:1346147 6480464 Dichlorodiphenyl Dichloroethylene inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 DDT multiple interactions ISO RGD:1346147 6480464 DDT inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of ALPL mRNA CTD PMID:23640034 desferrioxamine B decreases expression ISO RGD:731885 6480464 Deferoxamine results in decreased expression of ALPL mRNA CTD PMID:16772336 desferrioxamine B multiple interactions ISO RGD:1346147 6480464 Indomethacin promotes the reaction [Deferoxamine results in decreased expression of ALPL protein], Sulindac promotes the reaction [Deferoxamine results in decreased expression of ALPL protein] CTD PMID:21882223 desferrioxamine B decreases expression ISO RGD:1346147 6480464 Deferoxamine results in decreased expression of ALPL protein CTD PMID:21882223 dexamethasone multiple interactions ISO RGD:731885 6480464 [Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of ALPL mRNA more ... CTD PMID:15270777 , PMID:26492236 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of ALPL protein CTD PMID:28363435 dexamethasone multiple interactions EXP 6480464 caffeic acid phenethyl ester inhibits the reaction [Dexamethasone results in decreased expression of ALPL protein] CTD PMID:28363435 dexamethasone multiple interactions ISO RGD:1346147 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA more ... CTD PMID:26424790 , PMID:28628672 dexamethasone increases expression ISO RGD:1346147 6480464 Dexamethasone results in increased expression of ALPL mRNA CTD PMID:27608943 dextran sulfate multiple interactions ISO RGD:731885 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALPL mRNA CTD PMID:29950665 dextran sulfate increases activity ISO RGD:731885 6480464 Dextran Sulfate results in increased activity of ALPL protein CTD PMID:30489199 diallyl trisulfide increases expression ISO RGD:1346147 6480464 diallyl trisulfide results in increased expression of ALPL protein CTD PMID:19550292 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of ALPL mRNA CTD PMID:22465848 dibenz[a,h]anthracene increases expression ISO RGD:731885 6480464 1 more ... CTD PMID:26377693 dichloroacetic acid increases expression ISO RGD:731885 6480464 Dichloroacetic Acid results in increased expression of ALPL mRNA CTD PMID:28962523 diethylstilbestrol increases expression ISO RGD:731885 6480464 Diethylstilbestrol results in increased expression of ALPL mRNA CTD PMID:15289156 , PMID:15591538 difenoconazole increases activity EXP 6480464 difenoconazole results in increased activity of ALPL protein CTD PMID:28679351 difenoconazole multiple interactions EXP 6480464 Quercetin inhibits the reaction [difenoconazole results in increased activity of ALPL protein] CTD PMID:28679351 digoxin multiple interactions ISO RGD:731885 6480464 Digoxin inhibits the reaction [Ethinyl Estradiol results in increased secretion of ALPL protein] CTD PMID:36329302 dimethoate multiple interactions ISO RGD:1346147 6480464 Dimethoate inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 dioxygen multiple interactions ISO RGD:731885 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALPL mRNA, Oxygen deficiency inhibits the reaction [LIF protein affects the reaction ALPL mRNA] CTD PMID:26723917 , PMID:30529165 dioxygen increases expression ISO RGD:1346147 6480464 Oxygen deficiency results in increased expression of ALPL mRNA CTD PMID:26516004 diquat increases expression ISO RGD:731885 6480464 Diquat results in increased expression of ALPL mRNA CTD PMID:36851058 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ALPL mRNA CTD PMID:25152437 diuron increases expression EXP 6480464 Diuron results in increased expression of ALPL mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:731885 6480464 dorsomorphin inhibits the reaction [Bezafibrate results in increased expression of ALPL mRNA] CTD PMID:21499286 dorsomorphin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in increased secretion of ALPL protein] CTD PMID:27702592 doxorubicin decreases activity EXP 6480464 Doxorubicin results in decreased activity of ALPL protein CTD PMID:32810592 doxorubicin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Doxorubicin results in decreased activity of ALPL protein], Vitamin E inhibits the reaction [Doxorubicin results in decreased activity of ALPL protein] CTD PMID:32810592 enalapril multiple interactions EXP 6480464 Enalapril inhibits the reaction [Corticosterone results in decreased expression of ALPL mRNA], Enalapril inhibits the reaction [Ethanol results in decreased expression of ALPL mRNA] CTD PMID:30423288 , PMID:31887396 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of ALPL mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:731885 6480464 epoxiconazole results in decreased expression of ALPL mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:1346147 6480464 Ethanol results in decreased expression of ALPL mRNA CTD PMID:23378141 ethanol increases expression EXP 6480464 Ethanol results in increased expression of ALPL protein CTD PMID:36453646 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ALPL mRNA CTD PMID:31887396 ethanol multiple interactions EXP 6480464 Cannabinoids inhibits the reaction [Ethanol results in increased expression of ALPL protein], Enalapril inhibits the reaction [Ethanol results in decreased expression of ALPL mRNA] CTD PMID:31887396 , PMID:36453646 ethanol increases expression ISO RGD:731885 6480464 Ethanol results in increased expression of ALPL mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1346147 6480464 [Ethanol co-treated with Folic Acid] results in decreased expression of ALPL mRNA CTD PMID:23378141 eugenol increases expression ISO RGD:1346147 6480464 Eugenol results in increased expression of ALPL mRNA CTD PMID:22083529 Falecalcitriol increases expression ISO RGD:1346147 6480464 26 more ... CTD PMID:12016462 fenofibrate decreases expression ISO RGD:1346147 6480464 Fenofibrate results in decreased expression of ALPL mRNA CTD PMID:25572481 fenvalerate multiple interactions ISO RGD:1346147 6480464 fenvalerate inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA], fenvalerate inhibits the reaction [Progesterone results in increased activity of ALPL protein] CTD PMID:16326432 , PMID:29149346 fenvalerate increases activity EXP 6480464 fenvalerate results in increased activity of ALPL protein CTD PMID:15696646 ferric ammonium citrate multiple interactions ISO RGD:731885 6480464 ferric ammonium citrate results in decreased expression of and results in decreased activity of ALPL protein, Silybin inhibits the reaction [ferric ammonium citrate results in decreased expression of and results in decreased activity of ALPL protein] CTD PMID:36087815 Fexaramine multiple interactions ISO RGD:731885 6480464 fexaramine inhibits the reaction [Aflatoxin B1 results in increased secretion of ALPL protein] CTD PMID:37030333 fipronil multiple interactions ISO RGD:1346147 6480464 fipronil inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 folic acid multiple interactions ISO RGD:1346147 6480464 [Ethanol co-treated with Folic Acid] results in decreased expression of ALPL mRNA CTD PMID:23378141 formaldehyde increases expression ISO RGD:1346147 6480464 Formaldehyde results in increased expression of ALPL mRNA CTD PMID:22083529 fulvestrant multiple interactions ISO RGD:1346147 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ALPL gene more ... CTD PMID:12650720 , PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of ALPL mRNA CTD PMID:25539665 , PMID:26194646 gallocatechin increases expression EXP 6480464 gallocatechol results in increased expression of ALPL mRNA CTD PMID:21877759 gamma-aminobutyric acid decreases abundance ISO RGD:731885 6480464 ALPL gene mutant form results in decreased abundance of gamma-Aminobutyric Acid CTD PMID:7550313 gamma-hexachlorocyclohexane multiple interactions EXP 6480464 [Hexachlorocyclohexane co-treated with isoproturon] results in decreased activity of ALPL protein, [Hexachlorocyclohexane co-treated with isoproturon] results in increased expression of ALPL protein CTD PMID:11180283 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of ALPL protein CTD PMID:11180283 gamma-hexachlorocyclohexane increases activity EXP 6480464 Hexachlorocyclohexane results in increased activity of ALPL protein CTD PMID:11180283 genistein multiple interactions ISO RGD:1346147 6480464 [Genistein binds to ESR1 protein] which results in increased activity of ALPL protein, fulvestrant inhibits the reaction [[Genistein binds to ESR1 protein] which results in increased activity of ALPL protein] CTD PMID:12650720 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of ALPL mRNA CTD PMID:21782745 genistein increases expression ISO RGD:731885 6480464 Genistein results in increased expression of ALPL mRNA CTD PMID:15289156 glucose multiple interactions ISO RGD:731885 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL protein]] more ... CTD PMID:33450223 glucose multiple interactions EXP 6480464 morroniside inhibits the reaction [Glucose results in decreased expression of ALPL mRNA] CTD PMID:32643284 glucose decreases expression EXP 6480464 Glucose results in decreased expression of ALPL mRNA CTD PMID:32643284 glucose decreases expression ISO RGD:731885 6480464 Glucose results in decreased expression of ALPL mRNA CTD PMID:33450223 glycerol 2-phosphate increases hydrolysis ISO RGD:1346147 6480464 ALPL protein results in increased hydrolysis of beta-glycerophosphoric acid CTD PMID:18500657 glycerol 2-phosphate multiple interactions ISO RGD:731885 6480464 [ALPL protein results in increased degradation of beta-glycerophosphoric acid] which results in increased abundance of Phosphates more ... CTD PMID:17383965 , PMID:26492236 glycerol 2-phosphate increases expression ISO RGD:1346147 6480464 beta-glycerophosphoric acid results in increased expression of ALPL mRNA CTD PMID:18500657 glycerol 2-phosphate increases degradation ISO RGD:731885 6480464 ALPL protein results in increased degradation of beta-glycerophosphoric acid CTD PMID:17383965 glycerol 2-phosphate increases activity ISO RGD:1346147 6480464 beta-glycerophosphoric acid results in increased activity of ALPL protein CTD PMID:18500657 glycerol 2-phosphate multiple interactions ISO RGD:1346147 6480464 [ALPL protein results in increased hydrolysis of beta-glycerophosphoric acid] which results in increased abundance of Phosphates more ... CTD PMID:18500657 , PMID:26424790 glycyrrhetinate multiple interactions ISO RGD:731885 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased activity of ALPL protein] more ... CTD PMID:21910061 glycyrrhetinic acid multiple interactions ISO RGD:731885 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased activity of ALPL protein] more ... CTD PMID:21910061 GW 4064 increases expression ISO RGD:731885 6480464 GW 4064 results in increased expression of ALPL mRNA CTD PMID:26655953 hexachlorobenzene multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Hexachlorobenzene results in increased activity of ALPL protein] CTD PMID:30064338 hexachlorobenzene increases activity EXP 6480464 Hexachlorobenzene results in increased activity of ALPL protein CTD PMID:30064338 hexadecanoic acid multiple interactions EXP 6480464 acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of ALPL mRNA] more ... CTD PMID:24080574 hexadecanoic acid increases expression EXP 6480464 Palmitic Acid results in increased expression of ALPL mRNA CTD PMID:24080574 hexane decreases methylation EXP 6480464 n-hexane results in decreased methylation of ALPL promoter CTD PMID:23740543 hydrogen peroxide decreases expression ISO RGD:1346147 6480464 Hydrogen Peroxide results in decreased expression of ALPL mRNA CTD PMID:25130202 hydrogen peroxide multiple interactions ISO RGD:731885 6480464 myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of ALPL mRNA] CTD PMID:25130202 hydrogen peroxide decreases expression ISO RGD:731885 6480464 Hydrogen Peroxide results in decreased expression of ALPL mRNA CTD PMID:25130202 hydrogen peroxide multiple interactions ISO RGD:1346147 6480464 myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of ALPL mRNA] CTD PMID:25130202 hydroxychloroquine affects expression ISO RGD:1346147 6480464 Hydroxychloroquine affects the expression of ALPL mRNA CTD PMID:28975700 hydroxychloroquine multiple interactions ISO RGD:1346147 6480464 Hydroxychloroquine affects the reaction [Simvastatin affects the expression of ALPL mRNA] CTD PMID:28975700 icariside II increases expression EXP 6480464 baohuoside I results in increased expression of ALPL mRNA CTD PMID:17764702 icariside II increases secretion ISO RGD:731885 6480464 baohuoside I results in increased secretion of ALPL protein CTD PMID:35802278 indinavir multiple interactions ISO RGD:731885 6480464 AGN 193109 inhibits the reaction [Indinavir promotes the reaction [Tretinoin results in increased expression of ALPL protein]], Indinavir promotes the reaction [Tretinoin results in increased expression of ALPL protein] CTD PMID:10704935 indometacin multiple interactions ISO RGD:1346147 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ALPL mRNA more ... CTD PMID:21882223 , PMID:28628672 inulin multiple interactions ISO RGD:731885 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ALPL mRNA CTD PMID:36331819 isocyanuric acid increases expression EXP 6480464 cyanuric acid results in increased expression of ALPL protein CTD PMID:36152796 isoproturon multiple interactions EXP 6480464 [Hexachlorocyclohexane co-treated with isoproturon] results in decreased activity of ALPL protein, [Hexachlorocyclohexane co-treated with isoproturon] results in increased expression of ALPL protein CTD PMID:11180283 ketoconazole multiple interactions ISO RGD:1346147 6480464 Ketoconazole inhibits the reaction [Calcifediol results in increased expression of ALPL mRNA] CTD PMID:21542014 ketoconazole increases expression ISO RGD:731885 6480464 Ketoconazole results in increased expression of ALPL protein CTD PMID:31099283 L-ascorbic acid increases expression ISO RGD:1346147 6480464 Ascorbic Acid results in increased expression of ALPL mRNA CTD PMID:28105418 L-ascorbic acid multiple interactions ISO RGD:731885 6480464 [Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of ALPL mRNA more ... CTD PMID:26492236 L-ascorbic acid multiple interactions ISO RGD:1346147 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA, EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA] CTD PMID:26424790 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of ALPL protein CTD PMID:21712424 lead(0) decreases expression ISO RGD:731885 6480464 Lead results in decreased expression of ALPL mRNA CTD PMID:23086611 levamisole multiple interactions ISO RGD:1346147 6480464 Levamisole inhibits the reaction [beta-glycerophosphoric acid results in increased activity of ALPL protein], Levamisole inhibits the reaction [beta-glycerophosphoric acid results in increased expression of ALPL mRNA] CTD PMID:18500657 levamisole decreases activity ISO RGD:731885 6480464 Levamisole results in decreased activity of ALPL protein CTD PMID:27466191 levamisole increases response to substance ISO RGD:731885 6480464 ALPL gene mutant form results in increased susceptibility to Levamisole CTD PMID:27466191 levamisole multiple interactions ISO RGD:731885 6480464 [ALPL gene mutant form results in increased susceptibility to Levamisole] which results in increased expression of FOS mRNA CTD PMID:27466191 levonorgestrel multiple interactions ISO RGD:1346147 6480464 VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein] CTD PMID:12521655 lipopolysaccharide multiple interactions ISO RGD:1346147 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ALPL mRNA CTD PMID:35811015 lithocholic acid multiple interactions ISO RGD:1346147 6480464 [Lithocholic Acid co-treated with lysophosphatidic acid] results in increased activity of ALPL protein, EGF protein promotes the reaction [Lithocholic Acid results in increased activity of ALPL protein] CTD PMID:19646460 LY294002 multiple interactions ISO RGD:731885 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL protein]] CTD PMID:33450223 mandelic acid multiple interactions ISO RGD:1346147 6480464 [[Volatile Organic Compounds results in increased abundance of Styrene] which results in increased abundance of mandelic acid] which results in increased expression of ALPL protein CTD PMID:34668566 melatonin increases expression ISO RGD:1346147 6480464 Melatonin results in increased expression of ALPL mRNA CTD PMID:20738756 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Cadmium Chloride results in decreased activity of ALPL protein], Melatonin inhibits the reaction [Cadmium Chloride results in decreased expression of ALPL mRNA] CTD PMID:31809235 menadione decreases secretion ISO RGD:731885 6480464 Vitamin K 3 results in decreased secretion of ALPL protein CTD PMID:30453296 menaquinone increases expression EXP 6480464 Vitamin K 2 results in increased expression of ALPL protein CTD PMID:30639440 menaquinone multiple interactions EXP 6480464 PTH protein promotes the reaction [Vitamin K 2 results in increased expression of ALPL protein], Vitamin K 2 affects the reaction [PTH protein results in increased expression of ALPL protein] CTD PMID:30639440 menaquinone-4 increases activity ISO RGD:731885 6480464 menatetrenone results in increased activity of ALPL protein CTD PMID:11113387 methapyrilene decreases methylation ISO RGD:1346147 6480464 Methapyrilene results in decreased methylation of ALPL intron CTD PMID:30157460 methimazole increases expression EXP 6480464 Methimazole results in increased expression of ALPL mRNA CTD PMID:22504374 , PMID:30047161 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of ALPL mRNA CTD PMID:21782745 methoxychlor multiple interactions ISO RGD:1346147 6480464 Methoxychlor inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 methylparaben decreases expression ISO RGD:731885 6480464 methylparaben results in decreased expression of ALPL mRNA CTD PMID:28527915 microcystin-LR increases activity EXP 6480464 cyanoginosin LR results in increased activity of ALPL protein CTD PMID:36657700 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:731885 6480464 mono-(2-ethylhexyl)phthalate analog results in decreased expression of ALPL protein, mono-(2-ethylhexyl)phthalate results in decreased expression of ALPL protein CTD PMID:25777084 Morroniside increases expression ISO RGD:731885 6480464 morroniside results in increased expression of ALPL mRNA CTD PMID:34638983 , PMID:35848187 Morroniside multiple interactions EXP 6480464 morroniside inhibits the reaction [Glucose results in decreased expression of ALPL mRNA] CTD PMID:32643284 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of ALPL mRNA CTD PMID:21515302 myricitrin multiple interactions ISO RGD:731885 6480464 myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of ALPL mRNA] CTD PMID:25130202 myricitrin multiple interactions ISO RGD:1346147 6480464 myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of ALPL mRNA] CTD PMID:25130202 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:731885 6480464 [zinc chloride deficiency co-treated with N more ... CTD PMID:19913120 N-acetyl-L-cysteine multiple interactions ISO RGD:731885 6480464 Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of ALPL mRNA] CTD PMID:34547296 N-Acetyl-S- (3-hydroxypropyl)-cysteine multiple interactions ISO RGD:1346147 6480464 [[Volatile Organic Compounds results in increased abundance of Acrolein] which results in increased abundance of S-(3-hydroxypropyl)cysteine N-acetate] which results in increased expression of ALPL protein CTD PMID:34668566 N-Acetyl-S-(2-carbamoylethyl)-cysteine multiple interactions ISO RGD:1346147 6480464 [[Volatile Organic Compounds results in increased abundance of Acrylamide] which results in increased abundance of N-acetyl-S-(2-carbamoylethyl)cysteine] which results in increased expression of ALPL protein CTD PMID:34668566 N-Acetyl-S-(2-cyanoethyl)-cysteine multiple interactions ISO RGD:1346147 6480464 [[Volatile Organic Compounds results in increased abundance of Acrylonitrile] which results in increased abundance of N-acetyl-S-(2-cyanoethyl)cysteine] which results in increased expression of ALPL protein CTD PMID:34668566 N-methyl-4-phenylpyridinium increases expression ISO RGD:731885 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ALPL protein CTD PMID:26558463 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:1346147 6480464 Methylnitronitrosoguanidine results in increased expression of ALPL mRNA CTD PMID:12634122 N-nitrosodiethylamine multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein more ... CTD PMID:15548946 more ... N-tosyl-L-phenylalanyl chloromethyl ketone multiple interactions ISO RGD:731885 6480464 Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] CTD PMID:10567916 N-tosyl-L-phenylalanyl chloromethyl ketone multiple interactions EXP 6480464 Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] CTD PMID:10567916 N-tosyl-L-phenylalanyl chloromethyl ketone multiple interactions ISO RGD:1346147 6480464 Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] CTD PMID:10567916 naphthalene increases expression ISO RGD:731885 6480464 naphthalene results in increased expression of ALPL mRNA CTD PMID:18978301 nebivolol multiple interactions EXP 6480464 Nebivolol promotes the reaction [Alendronate inhibits the reaction [Methylprednisolone results in increased secretion of ALPL protein]] CTD PMID:30291735 niclosamide decreases expression ISO RGD:731885 6480464 Niclosamide results in decreased expression of ALPL mRNA CTD PMID:28824321 Nonylphenol multiple interactions ISO RGD:1346147 6480464 [nonylphenol binds to ESR1 protein] which results in increased activity of ALPL protein CTD PMID:12650720 ochratoxin A increases expression ISO RGD:731885 6480464 ochratoxin A results in increased expression of ALPL protein CTD PMID:35543154 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of ALPL mRNA CTD PMID:23665939 ozone multiple interactions ISO RGD:731885 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ALPL mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ALPL mRNA CTD PMID:34911549 pamidronate increases expression ISO RGD:1346147 6480464 pamidronate results in increased expression of ALPL protein CTD PMID:11683535 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ALPL mRNA CTD PMID:19784758 paracetamol decreases expression ISO RGD:1346147 6480464 Acetaminophen results in decreased expression of ALPL mRNA CTD PMID:21420995 , PMID:29067470 paracetamol affects expression ISO RGD:731885 6480464 Acetaminophen affects the expression of ALPL mRNA CTD PMID:17562736 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of ALPL mRNA CTD PMID:32680482 paricalcitol multiple interactions ISO RGD:1346147 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of ALPL mRNA CTD PMID:17715259 perfluoroheptanoic acid increases expression ISO RGD:731885 6480464 perfluoro-n-heptanoic acid results in increased expression of ALPL protein CTD PMID:36435305 perfluorohexanesulfonic acid increases expression ISO RGD:731885 6480464 perfluorohexanesulfonic acid results in increased expression of ALPL protein CTD PMID:29694846 perfluorononanoic acid decreases expression ISO RGD:1346147 6480464 perfluoro-n-nonanoic acid results in decreased expression of ALPL mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of ALPL mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:731885 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ALPL mRNA more ... CTD PMID:36331819 perfluorooctane-1-sulfonic acid increases expression ISO RGD:731885 6480464 perfluorooctane sulfonic acid results in increased expression of ALPL protein CTD PMID:26178269 perfluorooctane-1-sulfonic acid affects expression ISO RGD:1346147 6480464 perfluorooctane sulfonic acid affects the expression of ALPL mRNA CTD PMID:30738844 perfluorooctanoic acid increases expression ISO RGD:731885 6480464 perfluorooctanoic acid results in increased expression of ALPL protein CTD PMID:36435305 perfluorooctanoic acid decreases expression ISO RGD:1346147 6480464 perfluorooctanoic acid results in decreased expression of ALPL mRNA CTD PMID:23146750 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of ALPL mRNA, perfluorooctanoic acid results in increased expression of ALPL protein CTD PMID:19162173 , PMID:34958885 permethrin multiple interactions ISO RGD:1346147 6480464 Permethrin inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA], Permethrin inhibits the reaction [Progesterone results in increased activity of ALPL protein] CTD PMID:16326432 , PMID:29149346 phenethyl caffeate multiple interactions ISO RGD:731885 6480464 caffeic acid phenethyl ester inhibits the reaction [Carbon Tetrachloride results in increased activity of ALPL protein] CTD PMID:18436364 phenethyl caffeate multiple interactions EXP 6480464 caffeic acid phenethyl ester inhibits the reaction [Dexamethasone results in decreased expression of ALPL protein] CTD PMID:28363435 phenobarbital increases expression ISO RGD:731885 6480464 Phenobarbital results in increased expression of ALPL mRNA CTD PMID:19482888 phenobarbital multiple interactions ISO RGD:731885 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ALPL mRNA] CTD PMID:19482888 phenol increases expression ISO RGD:1346147 6480464 Phenol results in increased expression of ALPL mRNA CTD PMID:22083529 phosphorus atom multiple interactions ISO RGD:1346147 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of ALPL mRNA CTD PMID:17715259 phosphorus(.) multiple interactions ISO RGD:1346147 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of ALPL mRNA CTD PMID:17715259 phytoestrogen increases activity ISO RGD:1346147 6480464 Phytoestrogens results in increased activity of ALPL protein CTD PMID:16019205 phytoestrogen increases expression ISO RGD:1346147 6480464 Phytoestrogens results in increased expression of ALPL mRNA CTD PMID:16019205 pirinixic acid increases expression ISO RGD:731885 6480464 pirinixic acid results in increased expression of ALPL mRNA, pirinixic acid results in increased expression of ALPL protein CTD PMID:19176532 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ALPL mRNA CTD PMID:19162173 pirinixic acid multiple interactions ISO RGD:731885 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of ALPL mRNA], RXRA protein promotes the reaction [pirinixic acid results in increased expression of ALPL protein] CTD PMID:19176532 , PMID:20059764 potassium dichromate decreases activity EXP 6480464 Potassium Dichromate results in decreased activity of ALPL protein CTD PMID:16866188 procaine increases expression ISO RGD:1346147 6480464 Procaine results in increased expression of ALPL mRNA CTD PMID:22083529 progesterone multiple interactions ISO RGD:1346147 6480464 [Estradiol co-treated with Progesterone] results in increased expression of ALPL mRNA more ... CTD PMID:16326432 more ... progesterone decreases expression ISO RGD:1346147 6480464 Progesterone results in decreased expression of ALPL mRNA CTD PMID:21540246 progesterone increases expression ISO RGD:1346147 6480464 Progesterone results in increased expression of ALPL mRNA CTD PMID:17404688 progesterone increases activity ISO RGD:1346147 6480464 Progesterone results in increased activity of ALPL protein CTD PMID:16326432 pyridoxal 5'-phosphate increases abundance ISO RGD:731885 6480464 ALPL gene mutant form results in increased abundance of Pyridoxal Phosphate CTD PMID:7550313 pyrogallol increases expression ISO RGD:731885 6480464 Pyrogallol results in increased expression of ALPL mRNA CTD PMID:20362636 quercetin increases expression EXP 6480464 Quercetin results in increased expression of ALPL protein CTD PMID:26053266 quercetin multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased expression of ALPL protein] more ... CTD PMID:26053266 more ... raloxifene multiple interactions EXP 6480464 Raloxifene Hydrochloride inhibits the reaction [Decitabine results in increased expression of ALPL mRNA] CTD PMID:23385821 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of ALPL protein], resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ALPL mRNA] CTD PMID:11018766 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1346147 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ALPL mRNA CTD PMID:35811015 Salidroside increases activity ISO RGD:731885 6480464 rhodioloside results in increased activity of ALPL protein CTD PMID:24055767 Salidroside increases expression ISO RGD:731885 6480464 rhodioloside results in increased expression of ALPL mRNA CTD PMID:24055767 SB 203580 multiple interactions ISO RGD:731885 6480464 SB 203580 inhibits the reaction [(4-(7-chloroquinolin-4-yl)piperazino)(1-phenyl-5-(trifluoromethyl)-1H-pyrazol-4-yl)methanone promotes the reaction [BMP2 protein results in increased expression of ALPL mRNA]] CTD PMID:25789987 SB 431542 multiple interactions ISO RGD:1346147 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucosamine analog results in increased activity of ALPL protein] CTD PMID:20458730 silibinin multiple interactions ISO RGD:731885 6480464 Silybin inhibits the reaction [ferric ammonium citrate results in decreased expression of and results in decreased activity of ALPL protein] CTD PMID:36087815 silicon dioxide increases expression ISO RGD:731885 6480464 Silicon Dioxide results in increased expression of ALPL mRNA CTD PMID:29341224 simvastatin increases expression ISO RGD:731885 6480464 Simvastatin results in increased expression of ALPL mRNA CTD PMID:20417880 simvastatin multiple interactions ISO RGD:1346147 6480464 Hydroxychloroquine affects the reaction [Simvastatin affects the expression of ALPL mRNA] CTD PMID:28975700 simvastatin affects expression ISO RGD:1346147 6480464 Simvastatin affects the expression of ALPL mRNA CTD PMID:28975700 sirolimus multiple interactions ISO RGD:731885 6480464 Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]] CTD PMID:33450223 sodium arsenite affects methylation ISO RGD:1346147 6480464 sodium arsenite affects the methylation of ALPL gene CTD PMID:28589171 sodium arsenite decreases expression ISO RGD:1346147 6480464 sodium arsenite results in decreased expression of ALPL mRNA CTD PMID:29301061 sodium cholate multiple interactions ISO RGD:731885 6480464 [Cholesterol more ... CTD PMID:27394961 sodium fluoride affects expression EXP 6480464 Sodium Fluoride affects the expression of ALPL mRNA CTD PMID:25132241 sodium fluoride increases expression ISO RGD:1346147 6480464 Sodium Fluoride results in increased expression of ALPL protein CTD PMID:30259626 sodium fluoride multiple interactions EXP 6480464 DKK1 protein inhibits the reaction [Sodium Fluoride results in increased expression of ALPL mRNA] CTD PMID:24300170 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of ALPL mRNA CTD PMID:24300170 sodium hypochlorite increases expression ISO RGD:1346147 6480464 Sodium Hypochlorite results in increased expression of ALPL mRNA CTD PMID:22083529 sophoraflavanone B multiple interactions ISO RGD:1346147 6480464 [8-prenylnaringenin binds to ESR1 protein] which results in increased activity of ALPL protein, fulvestrant inhibits the reaction [[8-prenylnaringenin binds to ESR1 protein] which results in increased activity of ALPL protein] CTD PMID:12650720 sophoraflavanone B increases expression ISO RGD:1346147 6480464 8-prenylnaringenin results in increased expression of ALPL mRNA CTD PMID:16019205 sophoraflavanone B increases activity ISO RGD:1346147 6480464 8-prenylnaringenin results in increased activity of ALPL protein CTD PMID:16019205 spironolactone multiple interactions ISO RGD:1346147 6480464 Spironolactone inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 styrene multiple interactions ISO RGD:1346147 6480464 [[Volatile Organic Compounds results in increased abundance of Styrene] which results in increased abundance of mandelic acid] which results in increased expression of ALPL protein CTD PMID:34668566 sucrose multiple interactions EXP 6480464 [Dietary Fats co-treated with Sucrose] results in increased expression of ALPL protein, gamma-sitosterol inhibits the reaction [[Dietary Fats co-treated with Sucrose] results in increased expression of ALPL protein] CTD PMID:30461321 sulindac multiple interactions ISO RGD:1346147 6480464 Sulindac promotes the reaction [cobaltous chloride results in decreased expression of ALPL protein], Sulindac promotes the reaction [Deferoxamine results in decreased expression of ALPL protein] CTD PMID:21882223 syringic acid multiple interactions EXP 6480464 syringic acid inhibits the reaction [Valproic Acid results in increased activity of ALPL protein] CTD PMID:35543257 T-2 toxin decreases expression ISO RGD:731885 6480464 T-2 Toxin results in decreased expression of ALPL protein CTD PMID:35289972 tamoxifen decreases expression ISO RGD:731885 6480464 Tamoxifen results in decreased expression of ALPL mRNA CTD PMID:25123088 tamoxifen multiple interactions EXP 6480464 zinc chloride inhibits the reaction [Tamoxifen results in increased activity of ALPL protein] CTD PMID:31532279 tamoxifen increases activity EXP 6480464 Tamoxifen results in increased activity of ALPL protein CTD PMID:31532279 tamoxifen affects expression ISO RGD:731885 6480464 Tamoxifen affects the expression of ALPL mRNA CTD PMID:20937368 telmisartan increases activity EXP 329956421 telmisartan increases enzyme activity of Alpl in serum of rats with periodontal disease RGD terbutylazine multiple interactions ISO RGD:1346147 6480464 terbutylazine inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of ALPL mRNA CTD PMID:21515302 tetrachloroethene increases expression ISO RGD:731885 6480464 Tetrachloroethylene results in increased expression of ALPL mRNA CTD PMID:28973375 tetrachloromethane decreases expression ISO RGD:731885 6480464 Carbon Tetrachloride results in decreased expression of ALPL mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:731885 6480464 caffeic acid phenethyl ester inhibits the reaction [Carbon Tetrachloride results in increased activity of ALPL protein] CTD PMID:18436364 tetrachloromethane increases activity ISO RGD:731885 6480464 Carbon Tetrachloride results in increased activity of ALPL protein CTD PMID:18436364 tetraphene increases expression ISO RGD:731885 6480464 benz(a)anthracene results in increased expression of ALPL mRNA CTD PMID:26377693 thiamethoxam multiple interactions EXP 6480464 [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of ALPL protein] CTD PMID:30621503 thiamethoxam increases activity EXP 6480464 Thiamethoxam results in increased activity of ALPL protein CTD PMID:30621503 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ALPL mRNA CTD PMID:19784758 , PMID:34492290 titanium dioxide increases expression ISO RGD:1346147 6480464 titanium dioxide results in increased expression of ALPL mRNA CTD PMID:19464052 titanium dioxide multiple interactions ISO RGD:731885 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALPL mRNA CTD PMID:29950665 titanium dioxide increases expression ISO RGD:731885 6480464 titanium dioxide results in increased expression of ALPL mRNA, titanium dioxide results in increased expression of ALPL protein CTD PMID:21259345 more ... tramadol multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Tramadol results in increased expression of ALPL protein] CTD PMID:31618080 tramadol increases expression EXP 6480464 Tramadol results in increased expression of ALPL protein CTD PMID:31618080 tributylstannane multiple interactions ISO RGD:731885 6480464 tributyltin promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of ALPL mRNA] CTD PMID:22749964 tributylstannane decreases expression ISO RGD:731885 6480464 tributyltin results in decreased expression of ALPL mRNA, tributyltin results in decreased expression of ALPL protein CTD PMID:22749964 more ... triflumizole decreases expression ISO RGD:731885 6480464 triflumizol results in decreased expression of ALPL mRNA CTD PMID:23086663 trimellitic anhydride increases expression ISO RGD:731885 6480464 trimellitic anhydride results in increased expression of ALPL mRNA CTD PMID:19042947 triphenylstannane decreases expression ISO RGD:731885 6480464 triphenyltin results in decreased expression of ALPL protein CTD PMID:25777084 triptonide increases expression ISO RGD:731885 6480464 triptonide results in increased expression of ALPL mRNA CTD PMID:33045310 tungsten decreases expression ISO RGD:731885 6480464 Tungsten results in decreased expression of ALPL mRNA CTD PMID:30912803 tunicamycin multiple interactions ISO RGD:1346147 6480464 Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] more ... CTD PMID:10567916 tunicamycin multiple interactions EXP 6480464 Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]], Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein] CTD PMID:10567916 tunicamycin multiple interactions ISO RGD:731885 6480464 Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]], Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein] CTD PMID:10567916 tunicamycin increases degradation ISO RGD:1346147 6480464 Tunicamycin results in increased degradation of ALPL protein CTD PMID:10567916 uranium atom multiple interactions EXP 6480464 GHRL protein inhibits the reaction [Uranium results in decreased secretion of ALPL protein] CTD PMID:29477364 uranium atom decreases secretion EXP 6480464 Uranium results in decreased secretion of ALPL protein CTD PMID:29477364 valproic acid decreases methylation ISO RGD:1346147 6480464 Valproic Acid results in decreased methylation of ALPL gene CTD PMID:29154799 valproic acid increases activity EXP 6480464 Valproic Acid results in increased activity of ALPL protein CTD PMID:35543257 valproic acid multiple interactions EXP 6480464 Silymarin inhibits the reaction [Valproic Acid results in increased activity of ALPL protein], syringic acid inhibits the reaction [Valproic Acid results in increased activity of ALPL protein] CTD PMID:35543257 valproic acid increases expression ISO RGD:1346147 6480464 Valproic Acid results in increased expression of ALPL mRNA CTD PMID:23179753 valproic acid affects expression ISO RGD:731885 6480464 Valproic Acid affects the expression of ALPL mRNA CTD PMID:17292431 vancomycin increases expression ISO RGD:731885 6480464 Vancomycin results in increased expression of ALPL mRNA CTD PMID:18930951 vitamin E multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Doxorubicin results in decreased activity of ALPL protein] more ... CTD PMID:30064338 more ... warfarin multiple interactions ISO RGD:731885 6480464 Warfarin inhibits the reaction [BMP2 protein results in increased activity of ALPL protein] more ... CTD PMID:21910061 xanthohumol increases activity ISO RGD:1346147 6480464 xanthohumol results in increased activity of ALPL protein CTD PMID:16019205 xanthohumol increases expression ISO RGD:1346147 6480464 xanthohumol results in increased expression of ALPL mRNA CTD PMID:16019205 zearalenone multiple interactions ISO RGD:1346147 6480464 [Zearalenone binds to ESR1 protein] which results in increased activity of ALPL protein, fulvestrant inhibits the reaction [[Zearalenone binds to ESR1 protein] which results in increased activity of ALPL protein] CTD PMID:12650720 zinc atom increases expression EXP 6480464 Zinc results in increased expression of ALPL mRNA CTD PMID:16413754 zinc atom multiple interactions ISO RGD:731885 6480464 [Zinc binds to calcium silicate] which results in increased expression of ALPL mRNA CTD PMID:23483914 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of ALPL mRNA CTD PMID:21893222 zinc dichloride multiple interactions ISO RGD:731885 6480464 [zinc chloride deficiency co-treated with N more ... CTD PMID:19913120 zinc dichloride increases activity EXP 6480464 zinc chloride results in increased activity of ALPL protein CTD PMID:26214600 zinc dichloride multiple interactions EXP 6480464 Cadmium inhibits the reaction [zinc chloride results in increased activity of ALPL protein] more ... CTD PMID:26214600 , PMID:31532279 zinc(0) increases expression EXP 6480464 Zinc results in increased expression of ALPL mRNA CTD PMID:16413754 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of ALPL mRNA CTD PMID:21893222 zinc(0) multiple interactions ISO RGD:731885 6480464 [Zinc binds to calcium silicate] which results in increased expression of ALPL mRNA CTD PMID:23483914 zineb multiple interactions ISO RGD:1346147 6480464 Zineb inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 zoledronic acid decreases activity ISO RGD:731885 6480464 zoledronic acid results in decreased activity of ALPL protein CTD PMID:18496637 zoledronic acid multiple interactions ISO RGD:731885 6480464 TNFRSF11B protein affects the reaction [zoledronic acid results in decreased activity of ALPL protein] CTD PMID:18496637
